NORTHERN TRUST CORP - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 84 filers reported holding LEAP THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$51,997
-8.7%
152,931
+20.8%
0.00%
Q4 2022$56,952
-48.7%
126,5610.0%0.00%
Q3 2022$111,000
-13.3%
126,561
+13.9%
0.00%
Q2 2022$128,000
-34.0%
111,1220.0%0.00%
Q1 2022$194,000
-46.1%
111,1220.0%0.00%
Q4 2021$360,000
+21.2%
111,122
+50.3%
0.00%
Q3 2021$297,000
+112.1%
73,951
-13.1%
0.00%
Q2 2021$140,000
-13.6%
85,0640.0%0.00%
Q1 2021$162,000
-11.5%
85,064
+4.7%
0.00%
Q4 2020$183,000
+46.4%
81,266
+28.2%
0.00%
Q3 2020$125,000
+28.9%
63,378
+36.7%
0.00%
Q2 2020$97,000
+169.4%
46,354
+103.6%
0.00%
Q1 2020$36,000
+44.0%
22,7630.0%0.00%
Q4 2019$25,000
-7.4%
22,7630.0%0.00%
Q3 2019$27,00022,7630.00%
Other shareholders

There were no reported owners of LEAP THERAPEUTICS INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of LEAP THERAPEUTICS INC shareholders